多索茶碱片随机、开放、单剂量、两制剂、交叉设计在中国健康受试者中的生物等效性正式试验
[Translation] A formal bioequivalence study of doxofylline tablets in Chinese healthy subjects using a randomized, open-label, single-dose, two-formulation, crossover design
以上海凯宝新谊(新乡)药业有限公司提供的多索茶碱片为受试制剂;并以多索茶碱片(ABC Farmaceutici S.p.A.持证)为参比制剂,进行人体相对生物利用度和生物等效性评价。
[Translation] The doxofylline tablets provided by Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd. were used as the test preparation, and the doxofylline tablets (certified by ABC Farmaceutici S.p.A.) were used as the reference preparation to evaluate the relative bioavailability and bioequivalence in humans.
100 Clinical Results associated with Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd.
100 Deals associated with Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd.